We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.3B
AUM Growth
+$384M
Cap. Flow
+$216M
Cap. Flow %
9.39%
Top 10 Hldgs %
49.4%
Holding
255
New
116
Increased
33
Reduced
43
Closed
21

Top Buys

Rank Stock Value
1
KSPI icon
Kaspi.kz JSC
KSPI
+$20M
2
MREO
Mereo BioPharma
MREO
+$19.3M
3
BDX icon
Becton Dickinson
BDX
+$17.1M
4
SUNC
SunocoCorp LLC
SUNC
+$11.8M
5
MOH icon
Molina Healthcare
MOH
+$8.88M

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.7M
2
QURE icon
uniQure
QURE
+$26.4M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
SNDK
Sandisk
SNDK
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Financials 6.94%
3 Consumer Discretionary 6.7%
4 Industrials 3.7%
5 Technology 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZENA
201
ZenaTech Inc
ZENA
$124M
$410K 0.02%
+128,126
New +$534K
DTIL icon
202
Precision BioSciences
DTIL
$193M
$404K 0.02%
+97,085
New +$551K
CHCI icon
203
Comstock Holding Companies
CHCI
$159M
$397K 0.02%
+34,127
New +$467K
SRFM icon
204
Surf Air Mobility
SRFM
$91.8M
$394K 0.02%
+202,971
New +$649K
AKA icon
205
a.k.a. Brands
AKA
$122M
$390K 0.02%
+36,417
New +$439K
JFB
206
JFB Construction Holdings
JFB
$90.4M
$389K 0.02%
+53,192
New +$421K
MDXH icon
207
MDxHealth
MDXH
$22.3M
$384K 0.02%
+107,623
New +$425K
RILY icon
208
BRC Group Holdings
RILY
$298M
$374K 0.02%
+80,000
New +$396K
AGEN
209
Agenus
AGEN
$324M
$359K 0.02%
+114,336
New +$455K
ANIX icon
210
Anixa Biosciences
ANIX
$116M
$355K 0.02%
+113,636
New +$465K
RPID icon
211
Rapid Micro Biosystems
RPID
$105M
$350K 0.02%
+120,773
New +$419K
SCLX icon
212
Scilex Holding
SCLX
$45.9M
$333K 0.01%
+27,312
New +$461K
AMTX icon
213
Aemetis
AMTX
$109M
$327K 0.01%
+235,557
New +$474K
CRGO icon
214
Freightos
CRGO
$65.1M
$327K 0.01%
+143,269
New +$465K
PLCE icon
215
Children's Place
PLCE
$58M
$315K 0.01%
+79,210
New +$567K
ORIQ
216
Origin Investment Corp I
ORIQ
$89.2M
$304K 0.01%
30,000
– –
BBIO icon
217
BridgeBio Pharma
BBIO
$16.1B
$153K 0.01%
2,000
-298,000
-99% -$19.6M
ARCT icon
218
PUT
Arcturus Therapeutics
ARCT
$178M
$147K 0.01%
+24,000
New +$259K
GCTS.WS
219
GCT Semiconductor Holding Warrants
GCTS.WS
$17.9M
$53K ﹤0.01%
703,443
-60,948
-8% -$7.05K
BLUWW
220
Blue Water Acquisition Corp III Warrant
BLUWW
$3.91M
$39.8K ﹤0.01%
75,000
– –
LAFAR
221
LaFayette Acquisition Corp Rights
LAFAR
$33.8K ﹤0.01%
+250,000
New +$36.5K
CHECW
222
Chenghe Acquisition III Co Warrants
CHECW
$1.14M
$20K ﹤0.01%
+100,000
New +$19K
EVAC.WS
223
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$17.5K ﹤0.01%
50,000
– –
OYSER
224
Oyster Enterprises II Acquisition Corp Rights
OYSER
$15K ﹤0.01%
75,000
– –
LWACW
225
LightWave Acquisition Corp Warrants
LWACW
$2.8M
$13.5K ﹤0.01%
50,000
– –
7 8
9
10 11

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 683 Capital Management held 255 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $216M of net new capital in Q4 2025, opening 116 new positions and adding to 33 existing holdings. Its largest new stake was Kaspi.kz JSC: 265,000 shares worth $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Western Digital, an estimated $29.7M trimmed.

  • 683 Capital Management's largest Q4 2025 buy was Kaspi.kz JSC: 265,000 shares worth $20.7M.
  • 683 Capital Management added most to Mereo BioPharma in Q4 2025, an estimated $19.3M increase.
  • 683 Capital Management's biggest Q4 2025 reduction was Western Digital, cutting an estimated $29.7M.
  • 683 Capital Management fully exited Eli Lilly in Q4 2025, selling an estimated $21.8M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.3B portfolio in Q4 2025.
  • 683 Capital Management opened 116 new positions and closed 21 in Q4 2025.
  • 683 Capital Management's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on 683 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.